Learn more

What the World Cup’s tech stack has in common with a university spin-out

This year’s tournament is being called the most high-tech World Cup yet. Strip away the football and what’s left is a familiar pattern – sensors, wearables and AI, built on university research, trying to prove themselves on the biggest stage available.

The story

Every team at this year’s World Cup has access to an AI tool that analyses player movement and turns what used to be a 50 to 60 page analyst report into something a coaching staff can actually use. Every player was body-scanned before the tournament, in around a second, to build a digital avatar accurate enough to feed real-time officiating decisions. The match ball carries a sensor sampling 500 times a second. Referees wear body cameras. None of this is a gimmick for broadcast. It’s a live demonstration of exactly the translational pipeline that Read Marketing’s biotech and medtech clients work inside every day – research, sensors, data, and a very short window to prove the technology means something to the people watching.

Democratised access is a strategy, not a slogan

FIFA’s stated goal for this tournament was to give all 48 participating teams equal access to the same pre and post-match analytical capabilities, regardless of budget or squad size. The tool doing that work is Football AI Pro, a generative AI assistant that replaces lengthy static reports with something analysts and coaches can query directly. Previously, only the best-resourced federations had the staff to turn raw data into a usable game plan. This year, in theory, a smaller nation’s coaching team has the same starting point as the biggest.

That word – democratise – gets used constantly in medtech and diagnostics marketing too. A remote monitoring device, a decision-support tool, a diagnostic platform: the pitch is almost always that it puts capability into hands that didn’t have it before, whether that’s a rural GP practice or a smaller NHS trust without a specialist team on-site.

Worth remembering

The editor-in-chief of the journal Science and Medicine in Football recently told Nature that AI has driven a genuine surge in football research submissions – but that more data hasn’t automatically meant better science. Researchers are still working out how to handle the volume responsibly. It’s the same caution that applies to any AI-driven health technology claiming to democratise access: the tool reaching more people only counts if the output is still trustworthy once it gets there.

Sensor-embedded balls now relay movement data to officials 500 times a second

The hardware is, functionally, a sensor company

Take the branding away and the World Cup’s tech stack reads like a med-device product sheet. The official match ball has an internal inertial measurement unit sampling movement 500 times a second, relaying data on acceleration and position in three dimensions straight to the video assistant referee system. FIFA’s own testing manual now includes a balance test to make sure the sensor doesn’t affect how the ball actually flies – a reminder that instrumenting a physical object always means validating that the instrumentation hasn’t changed the thing you’re trying to measure.

The semi-automated offside system works the same way. Every player was 3D-scanned before the tournament to build a digital twin accurate enough to model fast or partially obstructed movement, and the system can now flag a player as offside by as little as 10cm, alerting officials through an earpiece in real time. It’s precise, but it has known limits – it can’t judge whether a player was interfering with play, and it struggles with players on the ground. FIFA hasn’t oversold what the system does. It’s marketed as decision support, not a replacement for judgement.

A digital twin built from a body scan and a wearable sensor sampling hundreds of times a second – the same underlying technology, aimed at a different outcome, is exactly what a growing number of medtech spin-outs are trying to commercialise.

The same translational pipeline, different endpoint

The universities Read Marketing works with day to day – Newcastle, Durham, Edinburgh, Strathclyde and beyond – all run active sports science, biomechanics and wearable sensor research alongside their biotech and medtech departments. The pathway from lab bench to product is structurally identical whether the outcome measured is a sprint time or a patient outcome: instrument the body, validate the sensor, prove the data means something, then get it in front of people who can act on it.

Where the science actually comes from

None of this technology arrived fully formed from a FIFA innovation lab. Impellizzeri’s account of the research landscape behind football will sound familiar to anyone working with a university spin-out. Most clubs and national teams now employ dedicated sport scientists, some running full data-science departments. PhD students are routinely embedded directly within teams, carrying out applied research while living the day-to-day demands of the squad – because, in Impellizzeri’s words to Nature, experiencing the practical challenges first-hand tends to produce research with more genuine real-world application.

That’s not a football insight. It’s a technology transfer insight. The spin-outs Read Marketing works with succeed for exactly the same reason: founders who understood the clinical or commercial problem from the inside, before they tried to build a product to solve it.

Where the science actually comes from

Even with a global broadcast audience and FIFA’s own communications machine behind it, this technology still needed explaining in plain terms. Nobody watching at home cares that a digital avatar is built from highly accurate body-part dimensions captured in a one-second scan. They care that the offside call is now fairer and faster. The technical achievement is not the story. The outcome is.

That’s the same discipline Read Marketing applies to every spin-out narrative: lead with the problem being solved and who it’s solved for, not the elegance of the underlying platform. A sensor sampling 500 times a second is an engineering fact. “Officials get a real-time answer instead of guessing” is the pitch.

  • Can you explain what your technology does in one sentence, with no jargon?
  • Have you led with the problem it solves, not the method behind it?
  • Is your evidence base strong enough to survive someone asking “how do you know that’s accurate?”
  • Are you being honest about what the technology can’t yet do, the way FIFA has been about offside edge cases?
  • Would a non-specialist – an investor, an NHS commissioner, a journalist – understand the value in ten seconds?

What Read Marketing takes from this

The technology behind this World Cup didn’t appear because football suddenly became a science. It appeared because the same translational pipeline that drives biotech and medtech innovation – university research, embedded specialists, instrumented data collection, careful validation, then a genuinely difficult communications job – was pointed at a different problem.

For the spin-outs Read Marketing works with across the North East and Scotland, the lesson isn’t about football. It’s a reminder that the hardest part of building deep-tech is rarely the technology itself. It’s translating precise, validated, sometimes genuinely brilliant science into a story that a non-expert can trust in the time it takes to watch a replay.

Sources

Got the science. Need the story?

Read Marketing works with biotech, medtech and medical device start-ups across the North East and Scotland to translate genuinely difficult science into a narrative investors, NHS partners and commercial audiences actually understand.

Talk to us

Leave a comment